Clinical Trials Logo

Femoracetabular Impingement clinical trials

View clinical trials related to Femoracetabular Impingement.

Filter by:
  • Active, not recruiting  
  • « Prev · Page 2

NCT ID: NCT03494660 Active, not recruiting - Clinical trials for Femoroacetabular Impingement

SCP Hip Outcomes Study

Start date: March 27, 2018
Phase:
Study type: Observational

Post-market clinical outcomes study to collect data on the short- and long-term outcomes for subjects who are undergoing or have undergone the Subchondroplasty® (SCP®) Procedure in the hip in a standard clinical setting. Outcomes to be assessed include medication usage, pain, function, activity levels and patient satisfaction.

NCT ID: NCT01546493 Active, not recruiting - Clinical trials for Femoroacetabular Impingement

Hip Impingement - Understanding Cartilage Damage

Start date: August 4, 2010
Phase: N/A
Study type: Interventional

Femoro-acetabular impingement (FAI) is a known cause of hip pain and possibly a major cause of adult hip osteoarthritis. The relationship between cam-type FAI deformity characteristics and joint degradation to better identify 'at-risk' patients requiring corrective surgery will be scrutinized to gain a better understanding of the condition's natural history. The influence of certain morphologies (e.g. size and location of the deformity) will be analyzed to determine if this leads to aberrant loading of regions of the cartilage and subchondral bone, resulting in cartilage damage and joint degradation. Additionally, this research will determine if changes in the subchondral bone precede cartilage degeneration. The methodology for establishing the morphology/cartilage degeneration relationship includes Magnetic Resonance Image (MRI) analysis, three-dimensional motion analysis and computer simulation/finite element analysis. The outcomes of this research may lead to a reduction in total hip replacement cases by as much as 70%, saving many Canadians from a painful and debilitating condition and reducing costs to the Canadian health care system by as much as $290 million annually.